Soft Tissue Radiation Injury; Patient Reported Evaluation in a Single Centre Cohort Study (STRIPE)
Recruiting
Observational Study
Cystitis, Radio InducedSoft Tissue Radionecrosis (STRN)Radiation Proctitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Karolinska University Hospital · Other
Who this trial is looking for
This trial is looking for adults with late radiation tissue injury who have received hyperbaric oxygen therapy (HBOT). Participants will help researchers understand how effective this treatment is and who benefits the most from it.
Are You a Good Fit for This Trial?
You may be able to join if
I am an adult over 18 years old
I have late radiation tissue injury
I have been treated with hyperbaric oxygen therapy
You may not be able to join if
I have requested not to be included in the study
I have not signed informed consent
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Radiotherapy cures many cancers but can cause late radiation-induced tissue injury (LRTI), leading to long-term symptoms from the bladder and bowel and reduced health-related quality of life (HRQoL). Hyperbaric oxygen therapy (HBOT) is an established treatment that reduces chronic inflammation and promotes tissue repair. Randomized studies have demonstrated improvements in symptoms and quality of …
Radiotherapy cures many cancers but can cause late radiation-induced tissue injury (LRTI), leading to long-term symptoms from the bladder and bowel and reduced health-related quality of life (HRQoL). Hyperbaric oxygen therapy (HBOT) is an established treatment that reduces chronic inflammation and promotes tissue repair. Randomized studies have demonstrated improvements in symptoms and quality of life, but only a small proportion of affected patients receive HBOT.
This study aims to longitudinally describe a cohort of patients with LRTI treated with HBOT at Karolinska University Hospital and to analyze associations between treatment, timing, and patient characteristics. The goal is to improve understanding of which patients benefit most from HBOT and when treatment should be initiated.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Adult patients (\>18 years old)
* Late radiation tissue injury
* Treated with HBOT
Exclusion Criteria:
* Requested not to be included in the study (Retrospective cohort)
* Not signed informed consent (Prospective cohort)
Inclusion Criteria:
* Adult patients (\>18 years old)
* Late radiation tissue injury
* Treated with HBOT
Exclusion Criteria:
* Requested not to be included in the study (Retrospective cohort)
* Not signed informed consent (Prospective cohort)
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.